BRPI0911719A2 - composição coccidiocida e seu uso - Google Patents

composição coccidiocida e seu uso

Info

Publication number
BRPI0911719A2
BRPI0911719A2 BRPI0911719A BRPI0911719A BRPI0911719A2 BR PI0911719 A2 BRPI0911719 A2 BR PI0911719A2 BR PI0911719 A BRPI0911719 A BR PI0911719A BR PI0911719 A BRPI0911719 A BR PI0911719A BR PI0911719 A2 BRPI0911719 A2 BR PI0911719A2
Authority
BR
Brazil
Prior art keywords
coccidiocidal
composition
coccidiocidal composition
Prior art date
Application number
BRPI0911719A
Other languages
English (en)
Inventor
Bernardo Lozano-Debernard
David Sarfati-Mizrahi
Ernesto Sotopriante
Héctor Salvador Sumano-Lopez
Luis Ocampocamberos
Original Assignee
Avi Mex S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Mex S A De C V Lab filed Critical Avi Mex S A De C V Lab
Publication of BRPI0911719A2 publication Critical patent/BRPI0911719A2/pt
Publication of BRPI0911719A8 publication Critical patent/BRPI0911719A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0911719A 2008-07-31 2009-07-30 composição coccidiocida e seu uso BRPI0911719A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.
PCT/IB2009/006409 WO2010013129A1 (es) 2008-07-31 2009-07-30 Combinación coccidicida para uso veterinario

Publications (2)

Publication Number Publication Date
BRPI0911719A2 true BRPI0911719A2 (pt) 2015-10-06
BRPI0911719A8 BRPI0911719A8 (pt) 2018-03-06

Family

ID=41610000

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911719A BRPI0911719A8 (pt) 2008-07-31 2009-07-30 composição coccidiocida e seu uso

Country Status (13)

Country Link
EP (1) EP2319515B1 (pt)
AR (1) AR072889A1 (pt)
BR (1) BRPI0911719A8 (pt)
CL (1) CL2011000208A1 (pt)
CO (1) CO6341549A2 (pt)
DK (1) DK2319515T3 (pt)
DO (1) DOP2011000030A (pt)
ES (1) ES2475266T3 (pt)
MX (1) MX2008009818A (pt)
PE (1) PE20110401A1 (pt)
PL (1) PL2319515T3 (pt)
PT (1) PT2319515E (pt)
WO (1) WO2010013129A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552477A (zh) * 2010-12-09 2012-07-11 天津瑞贝特科技发展有限公司 治疗鸡球虫病的中药组合物及其制备方法
ITTO20111219A1 (it) 2011-12-28 2013-06-29 Beta Renewables Spa Procedimento migliorato di pre-impregnazione per la conversione di biomassa
BR112017024363B1 (pt) * 2015-05-11 2023-03-14 Grupo Industrial Pecuario, S.A. De C.V Composições alimentícia compreendendo toltrazuril e trimetoprima e uso de uma combinação de toltrazuril e trimetoprima para o tratamento de parasitose por gregarinas em camarões

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454859B (sv) 1983-11-16 1988-06-06 Stig Olofsson Platta
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten

Also Published As

Publication number Publication date
CL2011000208A1 (es) 2011-05-06
MX2008009818A (es) 2010-02-01
CO6341549A2 (es) 2011-11-21
PE20110401A1 (es) 2011-07-24
EP2319515A1 (en) 2011-05-11
AR072889A1 (es) 2010-09-29
DOP2011000030A (es) 2011-04-15
DK2319515T3 (da) 2014-06-30
BRPI0911719A8 (pt) 2018-03-06
EP2319515B1 (en) 2014-05-07
ES2475266T3 (es) 2014-07-10
EP2319515A4 (en) 2011-12-21
PT2319515E (pt) 2014-05-27
WO2010013129A1 (es) 2010-02-04
PL2319515T3 (pl) 2014-10-31

Similar Documents

Publication Publication Date Title
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0821027A2 (pt) 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
CR20130360A (es) Compuesto heterocíclico y su uso
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI0816372A2 (pt) Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI0914595A2 (pt) material substituto de madeira e seu uso
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
BR112012002349A2 (pt) composto,e, uso do mesmo
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0813263A2 (pt) Oxazolidinonas substituídas e seu uso
BRPI0821668A2 (pt) Uso
BRPI0819573A2 (pt) Composição e artigo
DOP2010000260A (es) Derivado heterociclico fusionado y su uso
BR112013010988A2 (pt) composição fluída e uso
BRPI0913885A2 (pt) Tiadiazoliloxifenilamidinas e seus uso como fungicidas
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0918328A2 (pt) composição e artigo
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0913807A2 (pt) composição e artigo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements